Cimpress plc (CMPR) FY2026 Annual Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
Cimpress plc (CMPR) FY2026 Annual Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 2,202,511,000 US dollars
- Current assets
- 564,452,000 US dollars
- Non-current assets
- 1,638,059,000 US dollars
- Liabilities
- 2,600,788,000 US dollars
- Current liabilities
- 775,590,000 US dollars
- Non-current liabilities
- 1,825,198,000 US dollars
- Equity
- negative 473,844,000 US dollars
- Redeemable noncontrolling interests (Note 14)
- 75,567,000 US dollars
- Noncontrolling interest
- 20,141,000 US dollars. Included in consolidated equity; this amount is not added again.
- Cash and Cash Equivalent
- 248,851,000 US dollars
- Inventory
- 136,982,000 US dollars
- Prepaid expenses and other current assets
- 104,998,000 US dollars
- Accounts Receivable, after Allowance for Credit Loss, Current
- 73,621,000 US dollars
- Goodwill
- 850,778,000 US dollars
- Property, plant and equipment, net
- 367,160,000 US dollars
- Operating lease assets, net
- 121,022,000 US dollars
- Software and website development costs, net
- 106,788,000 US dollars
- Other assets
- 70,801,000 US dollars
- Intangible assets, net
- 70,580,000 US dollars
- Deferred tax assets
- 50,930,000 US dollars
- Accounts payable
- 333,252,000 US dollars
- Accrued expenses
- 324,744,000 US dollars
- Deferred revenue
- 48,534,000 US dollars
- Other current liabilities
- 29,687,000 US dollars
- Operating lease liabilities, current
- 24,753,000 US dollars
- Short-term debt
- 14,620,000 US dollars
- Long-term debt
- 1,597,361,000 US dollars
- Operating lease liabilities, non-current
- 102,549,000 US dollars
- Other liabilities
- 100,801,000 US dollars
- Deferred tax liabilities
- 24,487,000 US dollars
- Additional paid-in capital
- 623,454,000 US dollars
- Retained earnings
- 279,418,000 US dollars
- Ordinary shares, nominal value €0.01 per share, 100,000,000 shares authorized; 42,318,634 and 42,448,572 shares issued, respectively; 24,347,387 and 24,477,325 shares outstanding, respectively
- 596,000 US dollars
- Preferred shares, nominal value €0.01 per share, 100,000,000 shares authorized; none issued and outstanding
- 0 US dollars
- Noncontrolling Interest
- 20,141,000 US dollars
- Treasury shares, at cost, 17,971,247 shares for both periods presented
- negative 1,363,550,000 US dollars
- Accumulated other comprehensive loss
- negative 33,903,000 US dollars
Chart connections
- Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
